Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biocept Inc (BIOC)

Biocept Inc (BIOC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biocept Inc 5810 Nancy Ridge Drive San Diego CA 92121 USA

P: 858-320-8200 F: 267-757-3010

Description:

Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 66,206
Shares Outstanding, K 131,101
Annual Sales, $ 5,530 K
Annual Net Income, $ -25,140 K
Last Quarter Sales, $ 1,450 K
Last Quarter Net Income, $ -8,340 K
60-Month Beta 0.64
% of Insider Shareholders 0.32%
% of Institutional Shareholders 0.81%
Float, K 130,681
% Float 99.68%

Growth:

1-Year Return -59.84%
3-Year Return -98.89%
5-Year Return -99.83%
5-Year Revenue Growth 4,153.85%
5-Year Earnings Growth 99.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/13/20
Earnings Per Share ttm -0.91
EPS Growth vs. Prev Qtr 60.00%
EPS Growth vs. Prev Year 86.89%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-30 on 07/10/18

BIOC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -0.29
Price/Earnings to Growth N/A
Return-on-Equity % -185.80%
Return-on-Assets % -124.07%
Profit Margin % -454.61
Net Margin % 3.63
Debt/Equity 0.09
Price/Sales 10.90
Price/Cash Flow N/A
Price/Book 2.91
Book Value/Share 0.17
Interest Coverage -99.56
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar